m d anderson cancer center

(University of Texas M. D. Anderson Cancer Center) Low health literacy is a significant barrier to quality care, especially among elderly patients, but increased use of simple and effective health literacy assessment tests by nurses and clinicians can help improve communication and health outcomes.

(University of Texas M. D. Anderson Cancer Center) Like a bounty hunter returning escapees to custody, a cancer-fighting gene converts organ cells that change into highly mobile stem cells back to their original, stationary state, researchers report online at Nature Cell Biology.

(University of Texas M. D. Anderson Cancer Center) An essential protein for normal stem cell renewal also promotes the growth of breast cancer stem cells when it's overproduced in those cells, researchers at the University of Texas MD Anderson Cancer Center report in the February edition of Cancer Cell.

(University of Texas M. D. Anderson Cancer Center) In an international Phase III randomized study, everolimus, an inhibitor of the mammalian target of rapamycin (mTOR), has shown to dramatically improve progression-free survival for patients with advanced pancreatic neuroendocrine tumors (pNET), according to researchers from the University of Texas MD Anderson Cancer Center.

(University of Texas M. D. Anderson Cancer Center) miR-34a targets a surface protein common to cancer stem cells and associated with tumor development and metastasis.

When the micro RNA stifles CD44, it inhibits formation of prostate stem cells. Researchers blocked tumor formation, shrunk tumors and inhibited metastasis in mouse models.

(University of Texas M. D. Anderson Cancer Center) The interplay between a major tumor-suppressing gene, a truncated chromosome and two sets of microRNAs provides a molecular basis for explaining the less aggressive form of chronic lymphocytic leukemia, an international team of researchers reports today in the Jan. 4 edition of the Journal of the American Medical Association.

(University of Texas M. D. Anderson Cancer Center) A study of 781 people enrolled in a colorectal cancer prevention clinical trial finds that elevated levels of red blood cell folate is associated with the deactivation of two anti-cancer genes known to be silenced in colorectal cancer.

(University of Texas M. D. Anderson Cancer Center) A two-drug combination is safe and active in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome patients who are usually excluded from clinical trials because they have other illnesses or poor performance status -- a measure of disease progression -- researchers reported this week at the 52nd American Society of Hematology Annual Meeting.

(University of Texas M. D. Anderson Cancer Center) A $16-million, five-year grant by the National Cancer Institute's nanomedicine initiative blends the expertise of five research institutions to focus an array of innovative nanotechnologies on improving the outcome of patients with ovarian or pancreatic cancers.

(University of Texas M. D. Anderson Cancer Center) Digging more data out of lung CT scans to improve treatment of lung cancer and diagnosis of chronic obstructive pulmonary disease has earned a physician-scientist at The University of Texas MD Anderson Cancer Center a New Innovator Award from the National Institutes of Health.